Instos must be liking what they've heard.
And why not ? $50m cash, royalties to come from Bronchitol especially if US approval comes, huge royalty upside from Boehringer deal, and of course the new drugs in development too. Plus the cost base has come down massively.
A good proposition.
What is going on?, page-17
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $54.92M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.1¢ | 4.0¢ | $63.58K | 1.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 566236 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 221000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |